JP2013534527A - コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物 - Google Patents

コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物 Download PDF

Info

Publication number
JP2013534527A
JP2013534527A JP2013516909A JP2013516909A JP2013534527A JP 2013534527 A JP2013534527 A JP 2013534527A JP 2013516909 A JP2013516909 A JP 2013516909A JP 2013516909 A JP2013516909 A JP 2013516909A JP 2013534527 A JP2013534527 A JP 2013534527A
Authority
JP
Japan
Prior art keywords
dexpantenol
contact lens
composition
eye
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013516909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534527A5 (OSRAM
Inventor
ブライエン アンソニー ホールデン
Original Assignee
ブライエン ホールデン ビジョン インスティテュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902954A external-priority patent/AU2010902954A0/en
Application filed by ブライエン ホールデン ビジョン インスティテュート filed Critical ブライエン ホールデン ビジョン インスティテュート
Publication of JP2013534527A publication Critical patent/JP2013534527A/ja
Publication of JP2013534527A5 publication Critical patent/JP2013534527A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eyeglasses (AREA)
JP2013516909A 2010-07-02 2011-07-01 コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物 Pending JP2013534527A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010902954 2010-07-02
AU2010902954A AU2010902954A0 (en) 2010-07-02 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
PCT/AU2011/000827 WO2012000055A1 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Publications (2)

Publication Number Publication Date
JP2013534527A true JP2013534527A (ja) 2013-09-05
JP2013534527A5 JP2013534527A5 (OSRAM) 2014-08-21

Family

ID=45401233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013516909A Pending JP2013534527A (ja) 2010-07-02 2011-07-01 コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物

Country Status (9)

Country Link
US (2) US9161923B2 (OSRAM)
EP (1) EP2588096A4 (OSRAM)
JP (1) JP2013534527A (OSRAM)
CN (1) CN103037858A (OSRAM)
AU (1) AU2011274245B2 (OSRAM)
CA (1) CA2803935A1 (OSRAM)
SG (1) SG186782A1 (OSRAM)
TW (1) TW201206418A (OSRAM)
WO (1) WO2012000055A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US9161923B2 (en) * 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable
DK2898888T3 (da) * 2014-01-22 2019-06-03 Visufarma B V Sammensætning omfattende iota-carrageenan mod viral konjunktivitis
MX2017001812A (es) * 2014-08-08 2017-07-17 Shenzhen Hightide Biopharmaceutical Ltd Composiciones de formulacion liquida, aparatos de administracion de medicamentos, y metodos de preparacion y uso de los mismos.
EP3072503B1 (en) * 2015-03-26 2020-09-23 D.M.G. Italia Srl Ophthalmic composition for the corneal protection
EP3496516B1 (en) 2017-12-11 2020-02-19 Ion Beam Applications S.A. Superconductor cyclotron regenerator
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004521682A (ja) * 2001-01-09 2004-07-22 ルーイ・ヨハン・ワヘナール 眼を治療および／またはケアする方法と組成物
JP2004522993A (ja) * 2001-01-12 2004-07-29 ノバルティス アクチエンゲゼルシャフト デクスパンテノールを含有するレンズケア製品
JP2006501133A (ja) * 2001-12-12 2006-01-12 ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー 眼科学および鼻科学における適用のための薬学的組成物
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024425A1 (en) * 1998-10-27 2000-05-04 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20070243275A1 (en) 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
WO2009094466A2 (en) 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
PL2424374T3 (pl) 2009-05-01 2018-07-31 Advanced Vision Research, Inc. Kompozycje środka oczyszczającego i metody jego stosowania
IT1393712B1 (it) 2009-05-13 2012-05-08 Bruschettini Srl Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari
US9161923B2 (en) * 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004521682A (ja) * 2001-01-09 2004-07-22 ルーイ・ヨハン・ワヘナール 眼を治療および／またはケアする方法と組成物
JP2004522993A (ja) * 2001-01-12 2004-07-29 ノバルティス アクチエンゲゼルシャフト デクスパンテノールを含有するレンズケア製品
JP2006501133A (ja) * 2001-12-12 2006-01-12 ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー 眼科学および鼻科学における適用のための薬学的組成物
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015021945; Ｒａｃｚｙｎｓｋａ，　Ｋ．　ｅｔ　ａｌ．: 'Ｃｌｉｎｉｃａｌ　ｅｖａｌｕａｔｉｏｎ　ｏｆ　ｄｒｏｐｓ　ａｎｄ　ｇｅｌ　ｗｉｔｈ　ｐｒｏｖｉｔａｍｉｎ　Ｂ５　ｉｎ　ｐｏｓｔｏｐｅｒａｔｉｖｅ　ｔｒｅａｔｍｅｎｔ　ｏｆ　ｃｏｒｎｅａ　ａｎｄ　ｃｏｎ' Ｋｌｉｎｉｋａ　Ｏｃｚｎａ Ｖｏｌ．１０５　Ｎｏ．３-４, 2003, ｐ．１７５-１７８ *

Also Published As

Publication number Publication date
CA2803935A1 (en) 2012-01-05
AU2011274245B2 (en) 2014-07-17
US20130102679A1 (en) 2013-04-25
CN103037858A (zh) 2013-04-10
TW201206418A (en) 2012-02-16
WO2012000055A1 (en) 2012-01-05
AU2011274245A1 (en) 2013-01-10
EP2588096A1 (en) 2013-05-08
EP2588096A4 (en) 2013-12-25
US20160074345A1 (en) 2016-03-17
US9161923B2 (en) 2015-10-20
SG186782A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
US20250049761A1 (en) Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
US20230381016A1 (en) Ophthalmic composition and delivery device thereof
AU2011274245B2 (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
ES2461617T3 (es) Composiciones farmacéuticas acuosas que contienen complejos borato-polioles
US10780071B2 (en) Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
AU2011282683B2 (en) Preservative free brimonidine and timolol solutions
JP2022511335A (ja) 人工涙液組成物、コンタクトレンズ組成物及び薬剤ビヒクル組成物、並びにこれらの使用の方法
Chowhan et al. Ophthalmic preparations
HK1182338A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
US20120016027A1 (en) Composition and Method for Improved Lens Comfort
NZ623037B2 (en) Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150609

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151110